Renalytix Plc
(OTC) RNLX
Renalytix Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$2.35M
Net Income (TTM)
$28.03M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
RNLX News
RNLX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Renalytix Plc
Industry
Health Care Technology
Sector
Health CareEmployees
46
CEO
James Renwick McCullough, MBA
Website
renalytix.comHeadquarters
New York City, NY 10036, US
RNLX Financials
Key Financial Metrics (TTM)
Gross Margin
7%
Operating Margin
-13%
Net Income Margin
-15%
Return on Equity
-6%
Return on Capital
8%
Return on Assets
-4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$156.00K
Operating Income
$29.61M
EBITDA
$28.52M
Operating Cash Flow
$30.11M
Capital Expenditure
$4.00K
Free Cash Flow
$30.11M
Cash & ST Invst.
$4.68M
Total Debt
$8.54M
Renalytix Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$522.00K
+13.7%
Gross Profit
$100.00K
+332.6%
Gross Margin
19.16%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
102
N/A
Net Income
$4.73M
+53.4%
EBITDA
$4.03M
+54.0%
Quarterly Fundamentals
Net Cash
$7.34M
-320.3%
Accounts Receivable
$902.00K
-11.0%
Inventory
$0.00
N/A
Long Term Debt
$4.10M
-30.0%
Short Term Debt
$4.15M
-11.6%
Return on Assets
-4.20%
N/A
Return on Invested Capital
8.40%
N/A
Free Cash Flow
$3.84M
+59.6%
Operating Cash Flow
$3.84M
+59.6%